N-(4-cyanophenyl)-Glycine CAS:212322-56-0

The molecular properties of N-(4-cyanophenyl)-Glycine indicate its potential utility in different therapeutic areas, including neurology, oncology, and inflammatory disorders. In neurology, this compound may exhibit neuroprotective effects by modulating neurotransmitter signaling pathways or promoting neuronal survival. Research could explore its impact on neurodegenerative conditions like Alzheimer's or Parkinson's by investigating its ability to mitigate neuronal damage or enhance cognitive function. Furthermore, N-(4-cyanophenyl)-Glycine could also be examined for its potential as an anticancer agent in oncology. Studies may focus on its ability to inhibit tumor cell proliferation, induce apoptosis, or target specific molecular pathways involved in cancer progression. By elucidating the compound's mechanisms of action, researchers could potentially identify novel strategies for combating cancer and improving patient outcomes. In the realm of inflammatory diseases, N-(4-cyanophenyl)-Glycine may demonstrate anti-inflammatory properties that could be beneficial for conditions such as rheumatoid arthritis, inflammatory bowel disease, or autoimmune disorders. By modulating immune responses, cytokine production, or inflammatory mediators, this compound could offer therapeutic benefits in reducing inflammation and alleviating symptoms associated with chronic inflammatory conditions. Overall, the diverse pharmacological properties of N-(4-cyanophenyl)-Glycine underscore its potential as a valuable compound for drug discovery and development. Further investigation into its biological activities, mechanisms of action, and therapeutic effects across different disease settings could unlock new opportunities for addressing unmet medical needs and advancing treatment options for patients in various clinical contexts.